MedCity News November 16, 2023
Medical science has made significant strides in the development of advanced treatments over the past decade. However, the majority of FDA-approved treatments for Alzheimer’s focus on the management of symptoms or delayed progression of the disease.
Right now, roughly six million Americans are forgetting their lives as a result of Alzheimer’s— a devastating disease that progressively interferes with, and eventually destroys, cognitive function and memory— and unless we do something drastic about it, this number will more than double by 2050. That’s a tall order considering that both 2022 and 2023 were hailed as the “era of Alzheimer’s Disease treatments” and it’s likely that medical advancements for Alzheimer’s will continue strong well into 2024. As we learn more about the...
Today's Sponsors
Today's Sponsor